Key factors
sym | ACB |
exch | US |
MCap | 372.62M |
Beta | 2.833 |
EPS | -58.2 |
Div date | 0000-00-00 |
Yesterday
sym | ACB |
exch | US |
close | 6.535 |
50 Day MA | 4.114 |
200 Day MA | 4.924 |
52 Week High | 11.5 |
52 Week Low | 2.84 |
Target Price | 31.88 |
Market Cap Mln | 372.62 |
Share statistics
Shares Outstanding | 54.53M |
Shares Float | 54.39M |
Percent Institutions | 6.958 |
PercentInsiders | 0.011 |
SharesShort | 5076.51K |
Short Ratio | 3.04 |
Shares Short Prior Month | 3822.27K |
Short Percent | 20.41 |
Income
Revenue TTM | 275.88M |
Revenue Per Share TTM | 6.784 |
Quarterly Revenue Growth YOY | 5.499 |
Gross Profit TTM | 21.22M |
EBITDA | -33.3M |
Diluted Eps TTM | -58.2 |
Quarterly Earnings Growth YOY | -91.6 |
earning
Operating Margin TTM | -0.24 |
EPS Estimate Current Quarter | -0.01 |
EPS Estimate Current Year | -0.92 |
EPS Estimate Next Quarter | -0.01 |
EPS Estimate Next Year | -0.32 |
Earnings Share | -58.2 |
Dividend
Dividend Date | 2020-05-11 |
Last Split Date | 2024-02-20 |
Last Split Factor | 1:10 |
business
Enterprise Value Ebitda | -0.20 |
Enterprise Value Revenue | 1.613 |
Book Value /share | 10.85 |
Price Book MRQ | 0.979 |
Price Sales TTM | 1.350 |
ProfitMargin | 1.517 |
ReturnOnAssetsTTM | -0.08 |
ReturnOnEquityTTM | -1.37 |
Sector
Gic Group | Pharmaceuticals, Biotechnology & Life Sciences |
Gic Industry | Pharmaceuticals |
Gic Sector | Health Care |
Gic Sub Industry | Pharmaceuticals |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Codes
ISIN | CA05156X8843 |
CIK | 1683541 |
Code | ACB |
CUSIP | 05156X108 |
CountryISO | US |
Currency Code | USD |
Currency Name | US Dollar |
Exchange | NASDAQ |
Currency Symbol | $ |
fund
Type | Common Stock |
UpdatedAt | 2024-04-12 |
Home Category | Canadian |
info
Fiscal Year End | June |
Full Time Employees | 1130.0 |
IPODate | 2014-07-11 |
International Domestic | Domestic |
MostRecent Quarter | 2023-12-31 |
Contact
Name | Aurora Cannabis Inc |
Address | 2207 90B Street SW, Edmonton, AB, Canada, T6X 1V8 |
Country Name | USA |
Phone | 855 279 4652 |
Web URL | https://www.auroramj.com |
Logo URL | /img/logos/US/ACB.png |
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.